Expression of the novel co-stimulatory molecule B7-H4 by renal tubular epithelial cells

Kidney International

Volumn 70, Issue 12, 2006, Pages 2092-2099

  Chen, Y ^a   Yang, C ^a   Xie, Z ^a   Zou, L ^a   Ruan, Z ^a   Zhang, X ^a   Tang, Y ^a   Fei, L ^a   Jia, Z ^a   Wu, Y ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antigen presentation; B7 H4; Co cultured experiment; TEC; Tubular lesion

Indexed keywords

B7 ANTIGEN; B7 H4 ANTIGEN; CREATININE; GAMMA INTERFERON; INTERLEUKIN 2; LIGAND; LYSOZYME;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DISEASE SEVERITY; EGG; FROZEN SECTION; HEN; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOREGULATION; IN VITRO STUDY; INTERFERON PRODUCTION; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TUBULE DAMAGE; KIDNEY TUBULE EPITHELIUM; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE PROLIFERATION; MEMBRANOUS GLOMERULONEPHRITIS; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD80; BIOPSY; CELL COMMUNICATION; CELL DIVISION; CELL LINE; COCULTURE TECHNIQUES; EPITHELIAL CELLS; FLOW CYTOMETRY; GENE EXPRESSION; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; KIDNEY TUBULES; LYMPHOCYTE CULTURE TEST, MIXED; MICE; RNA, MESSENGER; T-LYMPHOCYTES; TRANSFECTION;

EID: 33845312330     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001867     Document Type: Article

References (43)

1. D'Amico G. Tubulointerstitium as predictor of progression of glomerular diseases. Nephron 1999; 83: 289-295.
2. Tipping PG, Holdsworth SR. T cells in glomerulonephritis. Springer Semin Immunopathol 2003; 24: 377-393.
3. Ikezumi Y, Kanno K, Karasawa T et al. The role of lymphocytes in the experimental progressive glomerulonephritis. Kidney Int 2004; 66: 1036-1048.
4. Kelly CJ. T cell regulation of autoimmune interstitial nephritis. J Am Soc Nephrol 1990; 1: 140-149.
5. Carreno BM, Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002; 20: 29-53.
6. Wahl P, Schoop R, Bilic G et al. Renal tubular epithelial expression of the costimulatory molecule B7RP-1 (inducible costimulator ligand). J Am Soc Nephrol 2002; 13: 1517-1526.
7. Yamada A, Salama AD, Sayegh MH. The role of novel T cell costimulatory pathways in autoimmunity and transplantation. J Am Soc Nephrol 2002; 13: 559-575.
8. Wu Q, Jinde K, Endoh M et al. Clinical significance of costimulatory molecules CD80/CD86 expression in IgA nephropathy. Kidney Int 2004; 65: 888-896.
9. Wu Q, Jinde K, Endoh M et al. Costimulatory molecules CD80 and CD86 in human crescentic glomerulonephritis. Am J Kidney Dis 2003; 41: 950-961.
10. Dong H, Zhu G, Tamada K et al. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999; 5: 1365-1369.
11. Latchman Y, Wood CR, Chernova T et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001; 2: 261-268.
12. Chapoval AI, Ni J, Lau JS et al. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol 2001; 2: 269-274.
13. Sica GL, Choi IH, Zhu G et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003; 18: 849-861.
14. Zang X, Loke P, Kim J et al. B7x: a widely expressed B7 family member that inhibits T cell activation. Proc Natl Acad Sci USA 2003; 100: 10388-10392.
15. Prasad DV, Richards S, Mai XM et al. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 2003; 18: 863-873.
16. Tringler B, Liu W, Corral L et al. B7-H4 overexpression in ovarian tumors. Gynecol Oncol 2006; 100: 44-52.
17. Tringler B, Zhuo S, Pilkington G et al. B7-H4 is highly expressed in ductal and lobular breast cancer. Clin Cancer Res 2005; 11: 1842-1848.
18. Ichikawa M, Chen L. Role of B7-H1 and B7-H4 molecules in down-regulating effector phase of T-cell immunity: novel cancer escaping mechanisms. Front Biosci 2005; 1: 2856-2860.
19. Choi IH, Zhu G, Sica GL et al. Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family. J Immunol 2003; 171: 4650-4654.
20. Krambeck AE, Thompson RH, Dong H et al. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival. Proc Natl Acad Sci USA 2006; 103: 10391-10396.
21. Kryczek I, Zou L, Rodriguez P et al. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 2006; 203: 871-881.
22. Collins M, Ling V, Carreno BM. The B7 family of immune-regulatory ligands. Genome Biol 2005; 6: 223.
23. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005; 23: 515-548.
24. Simon I, Zhuo S, Corral L et al. B7-H4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer. Cancer Res 2006; 66: 1570-1575.
25. Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int 1997; 51: 2-15.
26. Watanabe N, Gavrieli M, Sedy JR et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol 2003; 4: 670-679.
27. Sedy JR, Gavrieli M, Potter KG et al. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol 2005; 6: 90-98.
28. Khoury SJ, Sayegh MH. The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity 2004; 20: 529-538.
29. Rodig N, Ryan T, Allen JA et al. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol 2003; 33: 3117-3126.
30. Carter L, Fouser LA, Jussif J et al. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol 2002; 32: 634-643.
31. Keir ME, Liang SC, Guleria I et al. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J Exp Med 2006; 203: 883-895.
32. Saunders PA, Hendrycks VR, Lidinsky WA et al. PD-L2:PD-1 involvement in T cell proliferation, cytokine production, and integrin-mediated adhesion. Eur J Immunol 2005; 35: 3561-3569.
33. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 2004; 4: 336-347.
34. Yoshinaga SK, Whoriskey JS, Khare SD et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature 1999; 402: 827-832.
35. Coyle AJ, Gutierrez-Ramos JC. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat Immunol 2001; 2: 203-209.
36. Daha MR, van Kooten C. Is the proximal tubular cell a proinflammatory cell? Nephrol Dial Transplant 2000; 15(Suppl 6): 41-43.
37. Biancone L, Deambrosis I, Camussi G. Lymphocyte costimulatory receptors in renal disease and transplantation. J Nephrol 2002; 15: 7-16.
38. Chen Y, Zhang J, Li J et al. Expression of B7-H1 in inflammatory renal tubular epithelial cells. Nephron Exp Nephrol 2006; 102: e81-e92.
39. Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 1999; 56: 1627-1637.
40. Daniel L, Saingra Y, Giorgi R et al. Tubular lesions determine prognosis of IgA nephropathy. Am J Kidney Dis 2000; 35: 13-20.
41. Kim J, Myers AC, Chen L et al. Constitutive and inducible expression of b7 family of ligands by human airway epithelial cells. Am J Respir Cell Mol Biol 2005; 33: 280-289.
42. Daniel L, Sichez H, Giorgi R et al. Tubular lesions and tubular cell adhesion molecules for the prognosis of lupus nephritis. Kidney Int 2001; 60: 2215-2221.
43. Schoop R, Wahl P, Le Hir M et al. Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells. Nephrol Dial Transplant 2004; 19: 2713-2720.